Coppell Advisory Solutions LLC Liquidia Corp Transaction History

Coppell Advisory Solutions LLC

  • $606 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$6.27 - $8.15 $183,341 - $238,314
29,241 Added 599.2%
34,121 $3.6 Billion
Q2 2023

Aug 17, 2023
SELL
$6.63 - $9.9 $79,924 - $119,344
-12,055 Reduced 71.18%
4,880 $524 Million
Q1 2023

May 19, 2023
SELL
$5.72 - $7.91 $83,197 - $115,050
-14,545 Reduced 46.2%
16,935 $1.84 Billion
Q4 2022

May 19, 2023
BUY
$4.68 - $6.54 $147,326 - $205,879
31,480 New
31,480 $3.32 Billion

Others Institutions Holding LQDA

# of Institutions
162
Shares Held
36M
Call Options Held
1.79M
Put Options Held
380K
View Full List

About Liquidia Corp

LQDA Quotes by TradingView
  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Coppell Advisory Solutions LLC Portfolio

Follow Coppell Advisory Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coppell Advisory Solutions LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email